Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $364.50 million. The enterprise value is $138.57 million.

Market Cap	364.50M
Enterprise Value	138.57M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

CTNM has 25.78 million shares outstanding. The number of shares has increased by 488.88% in one year.

Current Share Class	19.05M
Shares Outstanding	25.78M
Shares Change (YoY)	+488.88%
Shares Change (QoQ)	+10.17%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	32.04%
Float	13.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.67
P/TBV Ratio	1.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 37.06, with a Debt / Equity ratio of 0.00.

Current Ratio	37.06
Quick Ratio	36.84
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -20.76% and return on invested capital (ROIC) is -15.84%.

Return on Equity (ROE)	-20.76%
Return on Assets (ROA)	-15.32%
Return on Capital (ROIC)	-15.84%
Revenue Per Employee	n/a
Profits Per Employee	-$931,839
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-161,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	17.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	30.57
Average Volume (20 Days)	78,509

Short Selling Information

The latest short interest is 1.12 million, so 4.34% of the outstanding shares have been sold short.

Short Interest	1.12M
Short Previous Month	952,350
Short % of Shares Out	4.34%
Short % of Float	8.53%
Short Ratio (days to cover)	20.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.52M
Pretax Income	n/a
Net Income	-28.89M
EBITDA	-43.30M
EBIT	-43.52M
Earnings Per Share (EPS)	-$2.14

Full Income Statement

Balance Sheet

The company has $213.91 million in cash and $611,000 in debt, giving a net cash position of $213.30 million or $8.27 per share.

Cash & Cash Equivalents	213.91M
Total Debt	611,000
Net Cash	213.30M
Net Cash Per Share	$8.27
Equity (Book Value)	210.23M
Book Value Per Share	8.17
Working Capital	209.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.35 million and capital expenditures -$657,000, giving a free cash flow of -$34.00 million.

Operating Cash Flow	-33.35M
Capital Expenditures	-657,000
Free Cash Flow	-34.00M
FCF Per Share	-$1.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-488.88%
Shareholder Yield	-488.88%
Earnings Yield	-8.20%
FCF Yield	-9.66%

Analyst Forecast

The average price target for CTNM is $29.25, which is 106.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.25
Price Target Difference	106.86%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CTNM has an Altman Z-Score of 46.66 and a Piotroski F-Score of 1.

Altman Z-Score	46.66
Piotroski F-Score	1